Navigation Links
Vapotherm Earns Achievement Award from U.S. Department Of Commerce
Date:11/7/2007

STEVENSVILLE, Md., Nov. 7 /PRNewswire-USNewswire/ - Vapotherm, the leading developer and manufacturer of High Flow Oxygen Therapy products, has earned an Export Achievement Certificate from the U.S. Department of Commerce.

Vapotherm was one of three Maryland companies to receive this designation at a recent ceremony in Wye Mills, Maryland. The Export Achievement Certificate was created by the U.S. Department of Commerce to recognize small and medium-sized enterprises that have successfully entered the international marketplace for the first time or that have successfully entered a new market.

"Vapotherm has been on a progressive international expansion course and we are now distributed in over 20 countries outside the U.S. and our success abroad has not only provided an important new technology for the global respiratory community, but it has also helped to strengthen our domestic base," said Kevin Thibodeau, Vice President of Sales and Marketing for Vapotherm. The US Department of Commerce Export Assistance and the State of Maryland Export Assistance has been a valuable resource for use as we expand globally.

"We are excited about Vapotherm's rapid growth in international markets. Vapotherm is a great example of a small company that is able to succeed internationally due to its advanced technology, corporate leadership and commitment to developing markets overseas. With ninety five percent of the world's market outside of the United States, Vapotherm is well positioned in these markets for future growth," said Bill Burwell, Director of the U.S. Commercial Service in Baltimore.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit '/>"/>

SOURCE Vapotherm, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
3. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
4. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
5. Abbott to Present at Bear Stearns Healthcare Conference
6. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
7. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
8. Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference
9. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
10. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
11. Cardiome to Present at Bear Stearns Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...PRNewswire/ -- NursingCenter.com, the premier site... reviewed content, has been,updated to improve th...d,users. Powered by Lippincott Williams & Wil...00 peer-reviewed continuing education activities a...50 leading nursing journals.,Lippincott Williams ...
(Date:11/21/2008)...wswire/ -- The general membership of the Medical,... individuals at their Annual,Awards Dinner to be ...York. A,Lifetime Achievement Award will also be g... Advertising Hall of Fame are: , Ronald Pantell...t position,at Sudler & Hennessey. In 1980 he ...
(Date:11/21/2008)...rugs do not cause genetic damage that can lead to ...ews) -- Two popular medications for treating atten...cause genetic damage linked to an increased risk f...tudy, done by researchers at Duke University Medic...ounters a previous one that reported biomarkers as...
(Date:11/21/2008)...wire/ -- In a statewide survey, 33 physicians cred...rgery at Presbyterian Hospital of Dallas were hono...of " Super Doctors ." , , Each year, the pu...onal Media, Inc. to survey more than 38,000 medica..."If you needed medical care, which doctor would yo...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
...ty for superstition and marketing to come together... are over-booked and Live Earth concerts as well a...s take place that day. "Number 7 has a magic sacr...ng luck," said numerologist Jean-Daniel Fermier. S...
...ina is expected to replace France as the world's t...ewed by a foreign news agency said China received ...ivals from Hong Kong, Macau, and Taiwan, compared ...978. They said that while tourism growth in Franc...
... moving out from her Sierra Towers apartment to le...apartment is at a very happening place, so the 'pa...ken car crash has decided not to go back there onc...rapy. "The Sierra Towers is party central," New Y...
...aginal lubricants control the growth of infection ... cervical cancer. The study was conducted by a t...ional Cancer Institute, Bethesda, Maryland. The p...experiments was that HPV survive only in humans, m...
Other Medicine News:Health News:A Lucky Number? 7/7/07 2Health News:A Lucky Number? 7/7/07 3Health News:China to Replace France as World's Top Tourism Destination by 2014 2Health News:Vaginal Lubricants can Reduce Cervical Cancer Risk 2
(Date:11/19/2008)...istical significance , , ISELIN, N.J., Nov.... (Nasdaq: PARS ) today announced results from it...ion (NE) drug delivery technology formulated with ...-center, randomized, double-blinded, placebo-contr...he Company,s 3% Diclofenac Diethanolamine NanoEmul...
(Date:11/18/2008)...all/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialt...nt Company,and Sosei Group Corporation ("Sosei";...l biopharmaceutical company, today announce that N...linical efficacy data for NSL-043/SD118.,This inv...pathic pain and has,successfully completed Phase ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...Watson, Marilyn & James Simons and,Sherry Lansing ... 12 J. Craig Venter,Ph...Institute (JCVI), was,awarded the Double Helix Med...vember 6th at a gala event in New York City., Dr.... Dr. James D.,Watson for making each of their indi...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ASTRO selects pediatric oncologist as 2008 honorary member 25838 1ASTRO selects pediatric oncologist as 2008 honorary member 25838 2Combination Therapy Helps to Combat Myeloma 25834 1Combination Therapy Helps to Combat Myeloma 25834 2Combination Therapy Helps to Combat Myeloma 25834 3Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 1Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 2Iowa State University researcher shows proteins have controlled motions 4624 1Iowa State University researcher shows proteins have controlled motions 4624 2
...patients treated with VELCADE, cyclophosphamide,a...ne 28, 2007 /PRNewswire-FirstCall/ -- Millennium,P...ation of results,from clinical trials of VELCADE b... / complete response(1) (CR) rates in previously,t...ngs were,presented at the prestigious 11th Interna...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003.
Athouritative, on the spot answers for acute care and consultations.
...de includes a specially designed, integrated retra... and handling. The Xstar Blade technology is base...al blades. This proprietary process yields outsta...single-bevel geometry allows the surgeon to create...
...de includes a specially designed, integrated retra... and handling. The Xstar Blade technology is base...al blades. This proprietary process yields outsta...single-bevel geometry allows the surgeon to create...
Medicine Products: